Login to Your Account



Corixa Sells Bexxar To GSK, Cuts Staff By 160 Employees

By Karen Pihl-Carey


Wednesday, December 15, 2004
With slower-than-expected sales growth of Bexxar, Corixa Corp. decided to turn worldwide rights for the non-Hodgkin's lymphoma product over to partner GlaxoSmithKline plc. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription